UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CAR-NK as a Rapidly Developed and Efficient Immunotherapeutic Strategy against Cancer

Cancers, 2022-12, Vol.15 (1), p.117

2022

Volltextzugriff (PDF)

NK Cell Degranulation Triggered by Rituximab Identifies Potential Markers of Subpopulations with Enhanced Cytotoxicity toward Malignant B Cells

International journal of molecular sciences, 2024-08, Vol.25 (16), p.8980

2024

Volltextzugriff (PDF)

Intestinal Microbiota in Common Chronic Inflammatory Disorders Affecting Children

Frontiers in immunology, 2021-06, Vol.12, p.642166-642166

2021

Volltextzugriff (PDF)

Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma

Leukemia, 2019-10, Vol.33 (10), p.2416-2428

2019

Volltextzugriff (PDF)

Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies

Cancer research (Chicago, Ill.), 2021-12, Vol.81 (23), p.6029-6043

2021

Volltextzugriff (PDF)

Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity

Scientific reports, 2022-11, Vol.12 (1), p.19660-14, Article 19660

2022

Volltextzugriff (PDF)

SHP1 Deficiency Is Responsible for the Constitutive Activation of the BCR Pathway in GCB DLBCL

BLOOD, 2018-11, Vol.132 (Supplement 1), p.2860-2860

2018

Volltextzugriff (PDF)

Endocytic proteins in the regulation of nuclear signaling, transcription and tumorigenesis

Molecular oncology, 2009-08, Vol.3 (4), p.321-338

2009

Volltextzugriff (PDF)

FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy

Oncoimmunology, 2018-05, Vol.7 (5), p.e1423183-e1423183

2018

Volltextzugriff (PDF)

Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway

Cancer research (Chicago, Ill.), 2005-01, Vol.65 (2), p.605-612

2005

Volltextzugriff (PDF)

Inhibition of Akt kinase signalling and activation of Forkhead are indispensable for upregulation of FasL expression in apoptosis of glioma cells

Oncogene, 2003-10, Vol.22 (48), p.7617-7627

2003

Volltextzugriff (PDF)

Cholesterol restricts lymphotoxin β receptor-triggered NF-κB signaling

Cell communication and signaling, 2019-12, Vol.17 (1), p.171-171, Article 171

2019

Volltextzugriff (PDF)

APPL1 regulates basal NF-κB activity by stabilizing NIK

Journal of cell science, 2012-09, Vol.125 (Pt 17), p.4090-4102

2012

Volltextzugriff (PDF)

Tumor Suppressor p53 Mediates Apoptotic Cell Death Triggered by Cyclosporin A

The Journal of biological chemistry, 2002-04, Vol.277 (16), p.14102-14108

2002

Volltextzugriff (PDF)

Abstract LB-261: Salinomycin expands the cytotoxicity of both anti-CD20 monoclonal antibodies and natural killer cells towards non-Hodgkin lymphomas

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.LB-261-LB-261

2019

Volltextzugriff (PDF)

Cyclosporin A-sensitive signaling pathway involving calcineurin regulates survival of reactive astrocytes

Neurochemistry international, 2001-04, Vol.38 (5), p.409-415

2001

Volltextzugriff (PDF)

Abstract B51: FOXO1 determines non-Hodgkin lymphomas response to anti-CD20-based therapy

Cancer research (Chicago, Ill.), 2018-05, Vol.78 (10_Supplement), p.B51-B51

2018

Volltextzugriff (PDF)

Abstract 1344: Improvement of the anti-tumor activity of NK cells and the efficacy of anti-CD20 monoclonal antibodies in the therapy of B cell-derived malignancies

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.1344-1344

2024

Volltextzugriff (PDF)

P14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3

The Journal of clinical investigation, 2012-04, Vol.122 (4), p.1283-1295

2012

Volltextzugriff (PDF)

Modulation of the composition of AP-1 complex and its impact on transcriptional activity

Acta neurobiologiae experimentalis, 2000-01, Vol.60 (3), p.395-402

2000

Volltextzugriff (PDF)

Abstract B14: Natural killer immune response is promoted by the treatment of B-cell lymphoma cancer cells with membrane ionophores

Cancer immunology research, 2020-03, Vol.8 (3_Supplement), p.B14-B14

2020

Volltextzugriff (PDF)

Lysosomal Disruption Augments Obinutuzumab-Induced Direct Cell Death

Blood, 2016-12, Vol.128 (22), p.2766-2766

2016

Volltextzugriff (PDF)

P14ARF Suppresses Tumor-Induced Thrombosis by Regulating the Tissue Factor Pathway

Cancer research (Chicago, Ill.), 2014-03, Vol.74 (5), p.1371-1378

2014

Volltextzugriff (PDF)

Inhibition of PIM Kinases in Diffuse Large B-Cell Lymphoma Cells Targets MYC-Dependent Transcriptional Program, Increases CD20 Expression and Augments the Efficacy of Anti-CD20 Antibodies

Blood, 2020-11, Vol.136 (Supplement 1), p.33-34

2020

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(45)
Berichte
(1)

Sprache

Englisch
(46)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

CAR-NK as a Rapidly Developed and Efficient Immunotherapeutic Strategy against Cancer

NK Cell Degranulation Triggered by Rituximab Identifies Potential Markers of Subpopulations with Enhanced Cytotoxicity toward Malignant B Cells

Intestinal Microbiota in Common Chronic Inflammatory Disorders Affecting Children

Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma

Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies

Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity

SHP1 Deficiency Is Responsible for the Constitutive Activation of the BCR Pathway in GCB DLBCL

Endocytic proteins in the regulation of nuclear signaling, transcription and tumorigenesis

FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy

Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway

Inhibition of Akt kinase signalling and activation of Forkhead are indispensable for upregulation of FasL expression in apoptosis of glioma cells

Cholesterol restricts lymphotoxin β receptor-triggered NF-κB signaling

APPL1 regulates basal NF-κB activity by stabilizing NIK

Tumor Suppressor p53 Mediates Apoptotic Cell Death Triggered by Cyclosporin A

Abstract LB-261: Salinomycin expands the cytotoxicity of both anti-CD20 monoclonal antibodies and natural killer cells towards non-Hodgkin lymphomas

Cyclosporin A-sensitive signaling pathway involving calcineurin regulates survival of reactive astrocytes

Abstract B51: FOXO1 determines non-Hodgkin lymphomas response to anti-CD20-based therapy

Abstract 1344: Improvement of the anti-tumor activity of NK cells and the efficacy of anti-CD20 monoclonal antibodies in the therapy of B cell-derived malignancies

P14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3

Modulation of the composition of AP-1 complex and its impact on transcriptional activity

HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies

Abstract B14: Natural killer immune response is promoted by the treatment of B-cell lymphoma cancer cells with membrane ionophores

Lysosomal Disruption Augments Obinutuzumab-Induced Direct Cell Death

P14ARF Suppresses Tumor-Induced Thrombosis by Regulating the Tissue Factor Pathway

Inhibition of PIM Kinases in Diffuse Large B-Cell Lymphoma Cells Targets MYC-Dependent Transcriptional Program, Increases CD20 Expression and Augments the Efficacy of Anti-CD20 Antibodies

Suchergebnisse filtern